Impact of Pharmacist-Led Educational Intervention on Hypertension Control in Diabetic Patients: a Multi-Center Randomized Control Study

被引:0
作者
Iqbal, Muhammad Shahid [1 ]
Iqbal, Muhammad Zahid [2 ]
Aziz, Sohail [2 ]
Alfaifi, Abdullah A. [1 ]
Albassam, Ahmed A. [1 ]
Ali, Abdul Nazer [3 ]
Upadhyay, Dinesh Kumar [3 ]
Alshehri, Ahmed M. [1 ]
Alahmari, Abdullah K. [1 ]
Almalki, Ziyad S. [1 ]
Prajapati, Sunil Kumar [4 ]
Gupta, Pushpraj S. [4 ]
Jamil, Ahmad Kamal Ariffin Abdul [5 ]
Al-Saikhan, Fahad, I [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Alkharj 11942, Saudi Arabia
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town 11800, Malaysia
[3] AIMST Univ, Fac Pharm, Dept Clin Pharm & Pharm Practice, Bedong 08100, Kedah, Malaysia
[4] Sam Higginbottom Univ Agr Technol & Sci, Dept Pharmaceut Sci, Allahabad, Uttar Pradesh, India
[5] UniSZA, Dept Clin Pharm & Pharm Practice, Fac Pharm, Terengganu 22200, Malaysia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2021年 / 40卷 / 11期
关键词
blood pressure; control group; DMTAC clinic; HbA1c; intervention group; type 2 diabetes mellitus; MEDICATION ADHERENCE; CONTROLLED-TRIAL; OUTCOMES; MANAGEMENT; DISEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes mellitus is a lifestyle modification disease that requires corporation from patients, which can be achieved by increasing patients' education level regarding the condition. In Malaysia, phar-macists are providing these services in DMTAC clinics in hospitals. The objective was to evaluate the influ-ence of pharmacist intervention on hypertension and its control in diabetic patients at different hospitals in Malaysia. The patients were randomly selected and divided into two groups. The control group contained 200 patients who were receiving traditional treatment from hospitals. In contrast, the intervention group included those 200 patients receiving standard treatment from hospitals and a separate counselling session with pharmacists from DMTAC clinics. The study continued for one year, and four follow up visits for both groups. Paired t-test and two-way ANOVA were used for parametric data, and Chi-square was used for non-parametric data analysis by SPSS v24. At the end of the study, a more significant reduction in HbA1c level was observed in the intervention group than the control group patients (3.59% vs. 2.17%; p < 0.001). Statistically, a significant reduction was also observed in Systolic (9.29 mmHg) and Diastolic (7.58 mm Hg) blood pressure of the patients (p < 0.005). With the intervention of pharmacist, not only the HbA1c was improved but hypertension in comorbidity also improved in patients. In the end, the intervention group of patients belongs to a pharmacist from the DMTAC department shows significant improvement in outcomes of diabetes mellitus.
引用
收藏
页码:2664 / 2671
页数:8
相关论文
共 25 条
  • [11] Jin Jing, 2008, Ther Clin Risk Manag, V4, P269
  • [12] Khan AH, 2021, J PHARM PHARMACOGN R, V9, P153
  • [13] Hypertension in type 2 diabetes: impact of glucose-lowering medications
    Krentz, Andrew J.
    [J]. CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (04): : 137 - 143
  • [14] Lim PC, 2016, PAK J PHARM SCI, V29, P595
  • [15] Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection
    Long, Amanda N.
    Dagogo-Jack, Samuel
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (04) : 244 - 251
  • [16] Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
    Maeng, Daniel D.
    Graham, Jove
    Bogart, Michael
    Hao, Jing
    Wright, Eric A.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 551 - 562
  • [17] Ministry of health and Child Care Zimbabwe, 2014, MAL STAT MED 2009 20, P1
  • [18] Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
    Perreault, L.
    Pan, Q.
    Aroda, V. R.
    Barrett-Connor, E.
    Dabelea, D.
    Dagogo-Jack, S.
    Hamman, R. F.
    Kahn, S. E.
    Mather, K. J.
    Knowler, W. C.
    [J]. DIABETIC MEDICINE, 2017, 34 (12) : 1747 - 1755
  • [19] Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
    Petrie, John R.
    Guzik, Tomasz J.
    Touyz, Rhian M.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (05) : 575 - 584
  • [20] Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
    Polonsky, William H.
    Henry, Robert R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 1299 - 1307